Analysis of DNA Fragmentation in Human Uterine Cervix Carcinoma HeLa S3Cells Treated with Duocarmycins or Other Antitumor Agents by Pulse Field Gel Electrophoresis
- 1 January 1993
- journal article
- Published by Wiley in Japanese Journal of Cancer Research
- Vol. 84 (1) , 93-98
- https://doi.org/10.1111/j.1349-7006.1993.tb02789.x
Abstract
Pulse field gel electrophoresis using a contour‐clamped homogeneous electric field was applied for the analysis of DNA‐fragmenting activity of antitumor agents towards human uterine cervix carcinoma HeLa S3 cells. Duocarmycins (DUMs), novel antitumor antibiotics with ultrapotent cell growth‐inhibitory activities, caused DNA fragmentation at 10 times their IC50 values at 2 h exposure. At 100 times their IC50 values, the size of the smallest fragments was about 245 kilobase pairs (kbp). DUMA, DUMB1 and DUMB2 exhibited similar DNA fragmentation patterns, suggesting similar action mechanisms. DNA fragmentation was also detected in cells treated with radical producers, intercalators and topoisomerase inhibitors. Two bands of about 1800 and 1500 kbp were commonly detected in the cells treated with DUMs and these agents. In addition, fragments of about 900 kbp were detected in the cells treated with a topoisomerase inhibitor, 4′‐(9‐acridinylamino)methane‐sulfon‐m‐anisidine, and fragments in the broad size range between 700 and 245 kbp in the cells treated with radical producers, bleomycin and neocarzinostatin. DUMs showed a characteristic DNA fragmentation pattern, since both types of fragments induced by the topoisomerase inhibitor and the radical producers were simultaneously detected, suggesting a novel mode of interaction with DNA. DNA‐crosslinking agents and mitotic inhibitors did not induce DNA fragmentation under these conditions. The pulse field gel electrophoresis is potentially useful for characterizing DNA‐cleaving activity of various antitumor agents at the cellular level.Keywords
This publication has 21 references indexed in Scilit:
- Anticellular and Antitumor Activity of Duocarmycins, Novel Antitumor AntibioticsJapanese Journal of Cancer Research, 1992
- Cell death induced by topoisomerase inhibitors: Role of calcium in mammalian cellsBiochemical Pharmacology, 1991
- Induction of heat-labile sites in DNA of mammalian cells by the antitumor alkylating drug CC-1065Biochemistry, 1991
- Synthesis and preliminary evaluation of agents incorporating the pharmacophore of the duocarmycin/pyrindamycin alkylation subunit: identification of the CC-1065/duocarmycin common pharmacophoreThe Journal of Organic Chemistry, 1990
- New antitumor antibiotics, duocarmycins B1 and B2.The Journal of Antibiotics, 1989
- Duocarmycin A, a new antitumor antibiotic from Streptomyces.The Journal of Antibiotics, 1988
- Free radical mechanisms in neocarzinostatin-induced DNA damageFree Radical Biology & Medicine, 1987
- Isolation and Structure of a Covalent Cross-Link Adduct Between Mitomycin C and DNAScience, 1987
- Separation of Large DNA Molecules by Contour-Clamped Homogeneous Electric FieldsScience, 1986
- Comparison of cytotoxicity and DNA breakage activity of congeners of podophyllotoxin including VP16-213 and VM26: a quantitative structure-activity relationshipBiochemistry, 1984